1. Green Tea (and Black Tea):

Rich in catechins and gallic acid, green and black teas can block xanthine oxidase, thereby reducing uric acid production. In fact, gallic acid in tea has one of the strongest XO-inhibiting effects, outperforming even other tea polyphenols. Enjoy 2–3 cups of unsweetened green or black tea daily (hot or iced). For example, have a cup in the morning instead of sugary beverages, or use cooled green tea as a base for smoothies. This provides a steady intake of XO-inhibiting compounds and can be a simple, soothing addition to your routine.

2. Coffee:

Moderate coffee consumption is associated with lower uric acid levels. Coffee contains chlorogenic acid (a polyphenol) and low doses of caffeine, which together inhibit xanthine oxidase and increase uric acid excretion. Essentially, chlorogenic acid in coffee acts similarly to allopurinol by occupying XO’s active site, thus preventing the formation of uric acid. If you tolerate caffeine, one or two cups of coffee a day (preferably black or low-sugar) can be beneficial. For instance, you might replace a mid-morning snack with a cup of black coffee or have it with breakfast. The diuretic effect of coffee’s polyphenols also helps flush out uric acid, but be sure to stay hydrated.

3. Tart Cherries (and Cherry Juice):

Tart cherries are famed as a home remedy for gout – and for good reason. They are high in anthocyanins, which not only have anti-inflammatory effects but may also inhibit xanthine oxidase. Studies have observed that regular tart cherry intake is linked to reduced serum uric acid and fewer gout flares. Cherry compounds can increase urate excretion and even showed a synergistic effect with allopurinol in research. You can drink an 8-ounce glass of 100% tart cherry juice daily (for example, in the morning or post-dinner), or eat a handful of fresh or frozen tart cherries as a snack. Alternatively, concentrated tart cherry capsules are available online. This sweet-tart fruit is an easy dessert swap that may help control uric acid levels.

4. Apples and Onions (Quercetin-Rich Foods):

Apples (especially with skins) and onions are high in quercetin, a flavonoid that inhibits xanthine oxidoreductase – the final step of uric acid synthesis. Quercetin has been shown in human studies to lower blood uric acid; for example, 500 mg of quercetin daily (equivalent to the quercetin in about one large red onion or several apples) significantly reduced serum urate in pre-hyperuricemic men. To get quercetin through diet, try eating an apple a day (as a snack or chopped into oatmeal) and use onions generously in cooking (soups, salads, stir-fries, etc.). Red onions, in particular, are very high in quercetin. By incorporating these foods regularly, you’ll get a consistent dose of this natural XO inhibitor alongside vitamins and fiber.

5. Celery and Celery Seeds:

Celery has long been used as a folk remedy for gout. Luteolin, a flavonoid abundant in celery (particularly in celery seeds), is a potent xanthine oxidase inhibitor. Research confirms that celery seed extracts can lower uric acid and block XO activity in animal models of hyperuricemia. You can integrate this by sprinkling celery seeds (about ¼ teaspoon) into soups, stews, or even smoothies – they have a mild, earthy flavor. Alternatively, steep celery seeds in hot water to make a tea, or take a celery seed extract supplement (readily available online). Eating fresh celery stalks is healthy too (as snacks or in salads), though the seeds have a higher concentration of luteolin. For example, you might add a pinch of ground celery seed to a vegetable juice or morning eggs for an extra anti-gout boost.

6. Ginger:

Common ginger root contains bioactive compounds (gingerols and shogaols) that have XO-inhibiting and anti-inflammatory properties. Notably, 6-gingerol in ginger has been shown to inhibit xanthine oxidase, thus interfering with the formation of uric acid. While ginger is often used to ease nausea or arthritis, it may also help keep uric acid in check by reducing production and oxidative stress. You can easily use fresh ginger in your diet: grate it into stir-fries, steep slices in hot water for a soothing ginger tea, or add it to smoothies and marinades. Even ginger powder can be used in curries or sprinkled on roasted vegetables. For instance, try drinking a cup of ginger tea after meals – not only is it calming for digestion, but it also provides those XO-inhibiting compounds in a warm, caffeine-free beverage.

7. Turmeric:

Turmeric (the golden-yellow spice) contains curcumin, which emerging research suggests can inhibit xanthine oxidase and also act as a uricosuric, helping the kidneys excrete uric acid. This dual action means turmeric might reduce uric acid both by producing less of it and by getting rid of it faster. In one clinical trial, curcumin supplements lowered serum urate about 7% (though results were comparable to placebo, indicating more research is needed). Regardless, turmeric’s anti-inflammatory benefits are well known and can be useful if you have any gouty joint pain. To incorporate turmeric, add ½–1 teaspoon of turmeric powder to your cooking daily – for example, stir it into soups, stews, or rice, or use it to make “golden milk” (turmeric latte) with milk/non-dairy milk and a pinch of black pepper (which boosts curcumin absorption). You can also take curcumin capsules available online for a concentrated dose. Be consistent; using a bit of turmeric every day – such as in scrambled eggs or a smoothie – can provide a steady supply of curcumin. (Tip: combine with black pepper and a healthy fat like olive oil when cooking, to enhance absorption of curcumin.)

Practical Tips: Aim to incorporate several of these options in your daily diet for a combined effect. For instance, you might start your day with a cup of green tea or coffee, enjoy an apple as a snack, use onions and ginger in your lunch/dinner recipe, and have a glass of tart cherry juice in the evening. Sprinkle in turmeric and celery seeds while cooking your meals. By using these natural xanthine oxidase inhibitors regularly, you can gradually lower uric acid levels.

Always remember to monitor your levels and consult with a healthcare provider for personalized guidance, but these additions are safe, accessible steps that leverage nature’s own XO inhibitors.

The post 7 Natural Dietary Xanthine Oxidase Inhibitors to Reduce Uric Acid appeared first on Medical Journal Daily.

Published in the medical journal JAMA, the study tracked participants from age 10 to 14. Although the overall amount of screen time didn’t reliably predict future suicidal behavior, the study found a much stronger link with compulsive digital habits. Children who struggled to disengage, became upset when unable to use their devices, or showed patterns of compulsive use were two to three times more likely to experience suicidal thoughts or make an attempt.

Lead researcher Dr. Yunyu Xiao emphasized that addictive behavior is a better predictor of risk than time spent on devices. “This is the first study to identify that addictive use is important, and is actually the root cause, instead of time,” she noted.

What Addictive Use Looks Like in Children

Addiction in this context doesn’t mean a child simply enjoys using their phone or video games. It refers to an emotional reliance where the child feels unable to stop, increasingly needs more time online to feel satisfied, or uses the device to escape emotional discomfort.

In the study, nearly half of the children displayed high levels of addictive behavior with mobile phones. About a quarter began with low signs of compulsive use, but their dependence grew rapidly over four years. By age 14, those in the “high or increasing use” groups were significantly more likely to report suicide-related behaviors.

Dr. Xiao explained that these behaviors are particularly difficult to manage in adolescents because their prefrontal cortex—the part of the brain responsible for impulse control—is still developing. This developmental stage may explain why some children struggle to disengage from apps or games, even when they are not spending excessive hours online.

How Parents and Policymakers Can Rethink the Problem

Traditionally, advice to parents has centered on limiting screen time with timers, parental control apps, or blanket restrictions. But the study’s findings suggest that focusing solely on the clock may miss children who are emotionally dependent on digital tools. Some children with moderate screen time showed high levels of psychological distress, while others with more hours logged did not.

Mental health experts are calling for a broader approach that includes behavioral assessments and therapy when needed. Cognitive behavioral therapy, in particular, has shown promise in addressing the compulsive patterns associated with addictive digital use.

The findings also raise questions about the role of technology companies. Dr. Mitch Prinstein of the American Psychological Association has urged lawmakers to push for “age-appropriate design” in digital platforms, a model already implemented in the United Kingdom. These design principles could limit persuasive features such as endless scrolling, autoplay, or algorithmic targeting, which are especially difficult for children to resist.

Parents are advised to pay attention not just to how long their children spend on screens, but to how they behave around them. Signs to watch for include frequent interruptions to check devices, visible distress when disconnected, or digital use crowding out sleep, school responsibilities, or time with others.

[Source: 1,2]

The post Study Finds Addictive Behavior Not Screen Time Alone Linked to Youth Suicide Risk appeared first on Medical Journal Daily.

Microparticles designed to release vaccines at set times

The research team’s approach involves packaging multiple doses of a vaccine into a single injection, using specially engineered microparticles that release each dose at a pre-programmed time. Instead of returning weeks or months later for a booster, a child could receive the entire course during one clinic visit.

The microparticles used in this vaccine system are built from a material group known as polyanhydrides. These particles are engineered as small, enclosed units that break down slowly once inside the body. As they degrade, they release the vaccine at specific intervals. The timing of this release depends on how the material is structured at the molecular level.

Mouse studies show immune response from delayed release

The team, led by researchers Ana Jaklenec and Robert Langer, recently demonstrated this timed delivery system in mice. The experiment involved two doses of a diphtheria vaccine: one released immediately and the second programmed to release two weeks later. The immune response in the mice mirrored what is typically seen when two separate injections are given weeks apart.

A major technical challenge was ensuring that the vaccine remains stable inside the microparticles during the delay between injection and release.

Traditional polymers like PLGA, which have been used for similar delivery systems, tend to create an acidic environment as they break down. This can damage sensitive biological materials like vaccines. The team chose polyanhydrides because they break down more slowly and produce less acidity, making them more suitable for carrying live or fragile antigens.

To identify the most effective versions of these materials, the team created a library of 23 polyanhydride types, each with slight variations in chemical makeup. They used a method called SEAL — stamped assembly of polymer layers — to form the particles and test their durability, sealing strength, and release performance.

After narrowing the list to the six most promising candidates, they tested them in mice.

Machine learning guides material design for timed release

To improve their material selection process, the researchers also developed a machine learning model. This algorithm predicted how changes in polymer composition would affect release timing, allowing them to screen hundreds of potential combinations virtually before testing a few in the lab.

Although still in early stages, this technology offers a possible shift in how vaccines are administered. If scaled successfully, it could benefit populations where returning for a second or third dose is a logistical challenge.

Clinics in rural areas, mobile vaccination units, and emergency response teams could all use a system that delivers complete protection in a single shot.

Potential for use in childhood vaccines and other treatments

Beyond childhood vaccines, the same method might be used to deliver other medications that require controlled timing, including hormone therapies or certain cancer treatments. For now, the immediate focus is on extending the interval between dose releases and testing the approach with other diseases like polio and measles.

This new form of vaccine delivery may not eliminate all barriers to global immunization, but it offers a practical way to reach more people with fewer resources.

By reducing the need for multiple appointments, it could help healthcare workers deliver lifesaving treatments more efficiently, especially in places where time and access are in short supply.

[Source]

The post How One Injection Could Deliver Multiple Vaccine Doses Ending the Need for Booster Shots appeared first on Medical Journal Daily.

The Hidden Risks of Dirty Humidifiers

Several studies have identified the growth of Legionella pneumophila, Pseudomonas aeruginosa, and fungal species like Aspergillus in improperly cleaned humidifiers. These pathogens can be aerosolized and inhaled, especially through ultrasonic or cool-mist humidifiers, which do not boil water before dispersal.

Studies have shown that neglected humidifiers can harbor bacteria and mold. Organisms such as Legionella pneumophila, Pseudomonas aeruginosa, and various fungal species have been found in humidifier tanks and internal components.

These pathogens can be aerosolized and inhaled, especially through ultrasonic or cool-mist humidifiers, which do not boil water before dispersal.

When the device is in use, these microbes can be released into the air along with the water vapor. Inhaling contaminated mist has been linked to a range of respiratory problems, including asthma flare-ups, lung inflammation, and hypersensitivity pneumonitis, a condition sometimes referred to as humidifier lung.

In December 2008, a large Legionella outbreak in a hospital neonatal unit was traced back to contaminated humidifiers, emphasizing the importance of disinfection even in controlled clinical environments.

CDC and EPA Recommendations on Humidifier Hygiene

According to the Centers for Disease Control and Prevention, one of the most important ways to prevent microbial growth in a humidifier is to avoid letting water sit in the tank for extended periods. The CDC recommends that users remove any remaining water from the humidifier each day, and allow the tank to dry completely.

The Environmental Protection Agency offers similar guidance for home humidifiers, emphasizing the importance of using distilled water rather than tap water, as minerals in untreated water can support bacterial growth.

Step-by-Step: How to Clean a Humidifier Safely

Daily Maintenance:

1. Unplug the humidifier and empty the tank.
2. Rinse all components with clean water.
3. Dry thoroughly.
4. Refill with fresh distilled water.

Weekly Deep Clean:

1. Disassemble the unit.
2. Prepare a cleaning solution by mixing one tablespoon of three percent hydrogen peroxide or white vinegar with each cup of water, then pour it into the tank.
3. Allow this solution to sit for about 20 to 30 minutes to loosen any buildup and gently scrub away any visible residue.
4. Once cleaned, rinse all parts thoroughly with clean water and let them dry completely before putting the unit back together.

Monthly Disinfection (or as recommended):

1. Use diluted bleach: 1 teaspoon per gallon of water.
2. Let it soak for 20 minutes, rinse several times with clean water.

Avoid using essential oils or additives unless the humidifier is designed for them, as they can promote residue buildup and bacterial growth.

Why This Matters in Healthcare and At Home

Indoor air quality plays an increasingly important role in public health, particularly as people spend more time indoors. Humidifiers, if improperly cleaned, can release fine droplets containing microbes and minerals into the air.

This adds to the overall particulate matter in enclosed spaces and can compromise air quality. According to environmental health studies, poor indoor air quality has been associated with increased rates of respiratory illnesses, allergic reactions, and chronic lung conditions.

Respiratory infections from contaminated humidifiers may go underdiagnosed or misattributed to other causes like seasonal allergies or viral infections. In clinical environments, especially where patients are immunocompromised, strict adherence to maintenance protocols can significantly reduce the risk of airborne transmission of pathogens.
[Source]

The post How to Clean Your Humidifier to Prevent Airborne Infections appeared first on Medical Journal Daily.

A Deadly Pattern That Repeats Every Summer

In over half of these incidents, the child is unintentionally left behind by a caregiver. These incidents do not typically result from neglect or recklessness. Often, they are the result of routine and distraction intersecting in a devastating way. In many cases, the child falls asleep in the backseat, and the caregiver continues on autopilot, unaware that the child is still in the car.

High stress, changes in routine, and fatigue are all contributing factors that can disrupt memory in dangerous ways.

From Classroom Idea to Working Prototype

That is the context behind an engineering capstone project completed by three students at Louisiana State University. Victoria Irondi, Nnamdi Dike, and Trevor Perrault created a smart car seat alert system designed to notify a caregiver when a child is left unattended in a vehicle.

Their design uses weight sensors in the seat and proximity sensors to track the caregiver’s distance. If the adult moves too far away, the system sends a Bluetooth signal to a handheld fob and triggers an alert.

The project was not just a classroom exercise. The idea originated with David Jenks, a sponsor of the capstone initiative, whose family friends had experienced a tragedy the previous summer. The students collaborated closely, shared code, tested prototypes, and refined their design over the course of several months.

Support From Safety Experts and Plans for the Future

Their work received recognition at the annual Child Passenger Safety Conference held in Baton Rouge on June 10.

Safety experts attending the conference, including certified child seat technicians and national advocates, praised the project for its practical design and potential affordability.

The students see this as only the beginning. With graduation behind them, they are now working on refining the technology. Planned improvements include enhancing sensor accuracy, reducing energy consumption, and designing a smaller form factor that can be more easily integrated into standard car seats. They are also exploring commercial partnerships and funding options for mass production.

Although the device is still a prototype, it represents something larger. It shows how student-led innovation, when directed toward real-world problems, can fill important gaps in public safety.

While federal regulations and automotive manufacturers have explored various solutions to hot car fatalities, a market-ready, affordable alert system is still not a standard feature in most vehicles.

Capstone projects, once purely academic, are increasingly used as platforms for applied problem-solving. In this case, the result is a tool that could directly prevent fatalities.
[Source]

The post How Three LSU Students Turned a College Project Into a Potential Solution for Hot Car Fatalities appeared first on Medical Journal Daily.

So why don’t more people know about it? The answer has less to do with chemistry and more to do with how we think about food, labels, and medicine.

The Quiet Risk in the Fruit Bowl

The issue isn’t new. Researchers identified in the early 1990s that grapefruit contains natural chemicals called furanocoumarins, which interfere with how certain medications are broken down in the body.

These naturally occurring chemicals block an enzyme in the gut known as CYP3A4, which normally helps break down many oral medications.

When this enzyme is blocked, the drug can build up in the body to toxic levels—without the patient doing anything wrong other than drinking juice.

This interaction often goes unnoticed because it rarely triggers symptoms right away. Instead, it slowly amplifies the strength of the drug over time, which can lead to unexpected complications.

So Why Aren’t People Paying Attention?

Despite the science, awareness of this interaction remains low. According to Dr. David Bailey, the clinical pharmacologist who first discovered the effect, many patients never see the warning at all.

Part of the problem is labeling. Medication guides often include a vague note like “Do not take with grapefruit juice” buried in sections most patients don’t read. Some labels only mention “citrus interactions” without explaining why or which fruits. And very few healthcare providers emphasize it unless directly asked.

Even more confusing: not all drugs within a class are affected. For example, while simvastatin interacts with grapefruit, pravastatin does not. Without specific guidance, patients may assume all statins are safe, or unsafe, creating more confusion.

Who’s Most at Risk?

Adults over the age of 45 are particularly at risk when it comes to grapefruit-related drug interactions. This age group is more likely to take multiple prescription medications daily, many of which fall into the category of drugs affected by grapefruit.

They also tend to consume grapefruit or its juice more regularly as part of heart-healthy diets. Compounding the risk is the fact that drug metabolism tends to slow down with age, making older adults less capable of handling sudden spikes in medication levels.

A dangerous combination can occur when someone starts a “healthy eating plan” that includes grapefruit without consulting their doctor. And because older adults have less ability to adjust to high drug concentrations, the consequences can include low blood pressure, kidney damage, internal bleeding, and even sudden cardiac death.

A Real-World Reminder

Consider this: A 68-year-old retiree in Mumbai began eating a half grapefruit each morning after watching a wellness segment on TV. She was already on blood pressure medication, but the label said nothing about grapefruit. Within a week, she experienced dizzy spells and ended up hospitalized with dangerously low blood pressure.

Only later did her doctors trace the problem back to her “healthy” breakfast choice. It wasn’t negligence—it was a gap in communication.

Fruits like Seville oranges, along with pomelos and certain varieties of limes, also contain furanocoumarins, the same compounds responsible for grapefruit’s drug interactions.

Most people wouldn’t think twice about tossing a bit of citrus into a salad or squeezing some into a drink, but when you’re on specific medications, even these seemingly minor additions can intensify the effects and pose unexpected health risks.

And here’s what’s truly concerning: these interactions can happen even if you eat the fruit hours before or after your medication. That’s because CYP3A4 remains blocked for up to 24 hours or more after exposure.

What Needs to Change?

Addressing the risk requires more than just clearer labeling. Healthcare providers—doctors, pharmacists, and even trusted medical websites—need to make it standard practice to inform patients about grapefruit interactions, especially when prescribing drugs known to be affected.

Patients, in turn, should be proactive: they should ask whether their prescriptions interact with grapefruit or related citrus fruits, read the full medication leaflets instead of relying solely on sticker warnings, and inform their healthcare provider about any new dietary habits, even ones that seem as harmless as adding fruit to breakfast.

Most interactions with grapefruit are avoidable. Many drugs have safe alternatives. And for those that don’t, skipping grapefruit is a small sacrifice for preventing serious complications.

In an age when personalized medicine is becoming the norm, we shouldn’t be tripped up by a breakfast fruit. But until warnings are clearer—and awareness is higher—this forgotten label will keep putting people at risk.

[Source: 1,2]

The post How Grapefruit Can Accidentally Overdose Your Medication appeared first on Medical Journal Daily.

The report is concise and publicly available, offering verified information about the spread of infectious diseases such as COVID-19, cholera, influenza, and pertussis. Though modest in presentation, it fills a gap left by inconsistent federal updates and shifting reporting standards.

A Consistent Source Amid Patchy Data

Launched in 2024, the Tracking Report was developed by a team led by Jennifer Nuzzo, an epidemiologist and director of the Pandemic Center at Brown’s School of Public Health. “There wasn’t a single place that offered a snapshot of global outbreaks,” she said. “So we created what we needed.”

The newsletter pulls together information from the US Centers for Disease Control and Prevention, state health departments, and international health agencies. In some cases, it provides data such as hospitalization rates or vaccination status that isn’t always included in national summaries.

Who Reads It and How It’s Used

The Tracking Report has been adopted by a wide range of readers. Public health departments consult it to stay updated on regional trends. Educators use it to support classroom discussions. Some senior living communities reference it to assess risk for residents.

Carolyn Needleman, a retired professor now living in Providence, says she started reading it during the COVID-19 pandemic and has continued since. “It’s become a routine check-in,” she said. “It’s practical.”

At the University of Wisconsin-Milwaukee, Dr. Loren Galvão uses the report as a classroom resource. “The source matters,” she said. “And I trust this one.”

How It Works

The report is compiled manually by the Pandemic Center’s research team, who review available data each week. They summarize key figures—such as rising pertussis cases, new regional outbreaks, or increases in child flu deaths—and include links to primary sources when available.

Each edition includes a short commentary from Dr. Nuzzo that frames the data in context. For instance, a recent edition noted a sharp rise in pertussis among children under five and discussed how vaccination rates may be influencing its spread.

While the information is technical, the writing avoids academic jargon. The goal is to offer clear, evidence-based updates without speculation or alarm.

A Model for Future Health Communication?

Though it began as an internal solution, the Tracking Report now functions as a tool for broader public use. Its open-access format and consistent schedule have drawn attention from health professionals seeking more reliable alternatives to irregular public dashboards.

The format is straightforward: bullet-point summaries, short context notes, and curated links. There’s no push to interpret the data for the reader—just an effort to make it accessible.

According to readers and contributors, the success of the tracker lies in its neutrality and focus. “It gives you what you need to know,” said Needleman. “Not more, not less.”

Looking Ahead

With global disease threats continuing to shift, the role of non-governmental reporting tools may grow. The Tracking Report isn’t intended to replace public health agencies, but it does illustrate what timely, transparent communication can look like—especially when built by teams grounded in public health research.

As Dr. Nuzzo put it, “We need ways to understand what’s happening now, not just what happened last month. That’s what this report aims to provide.”

[Source]

The post A University Tool That Tracks Global Outbreaks in Real Time appeared first on Medical Journal Daily.

A Quiet Shift in Winter 2024-25

Behind the scenes, however, America’s youngest experienced a very different RSV season. This was the first time two preventive interventions—a pandemic-era maternal vaccine and a monoclonal antibody injection—were widely available.

The first is given in third-trimester pregnancy; the second, a drug called Nirsevimab, to newborns in RSV season or, alternatively, as soon as they re-enter it. Both give infants pre-made defenses before their own immune systems can mount a defense.

This was then followed by a dramatic decrease in infant hospitalizations. The CDC said that infants under two months experienced a decline of as much as 71% from pre-pandemic years. For all infants under seven months of age, it was as much as a decline of 56%—a seismic change in children’s health.

During a more severe virus season than usual, not as many babies found themselves in intensive care, hooked up to machines to breathe or sucking to unclog lungs.

Why The Youngest Benefited Most

Timing was everything. Babies delivered during RSV season received either direct monoclonal protection or protective antibodies from vaccinated mothers.

These treatments were often given before symptoms had a chance to set in. And since these treatments target only the virus’s entry mechanisms, they serve as a targeted protection—instead of a broad immune system enhancement.

Earlier in the season, babies who were delivered experienced the most reliable protection, particularly in areas where the resources were provided in a timely manner.

While children older than eight months—most of whom did not qualify for either intervention—experienced a different pattern, hospitalizations for children aged 1–4 years and 5–17 years actually increased during this past winter.

Experts attribute this not to a behavioral or testing change but to a lack of protection. That is, older children faced a more robust virus season with no additional defenses.

What’s Next for Prevention of RSV?

Take Carla, a nurse from rural Oregon. Her five-year-old daughter was born mere months prior to the vaccine’s clearance. At age eight weeks, she came down with RSV and was airlifted to a hospital 100 miles away. “She spent three days in an oxygen tent,” Carla remembers. “I saw her ribs caving in with each breath. I’d have done anything to avoid that.” And yet, now, she’s pregnant again—but with a difference: a vaccine.

Public health experts hold out hope. With increasing coverage and providers delivering interventions early in each season, gains could grow.

This winter provided a glimpse of what can happen with widespread, timely protection. But it also made clear that continued education, access to underserved populations, and attention to older children still vulnerable to it remained priorities.

What started quietly—two newly available doses—has transformed the RSV story for infants. The hospital beds previously filled with ailing newborns can, in time and forethought, become a less common occurrence.

[Source: 1,2]

The post RSV Shots Cut Baby Hospitalizations by Over Half This Winter appeared first on Medical Journal Daily.

SPVX02 is formulated using the company’s proprietary StablevaX™ technology, which enables existing vaccines to remain stable at room temperature. In preclinical tests, the vaccine retained its efficacy after undergoing three cycles of temperature fluctuations between -20°C and 40°C. This kind of thermal resilience is rare among biologics and critical to improving vaccine access in low-resource or remote settings.

Tackling Vaccine Waste Through Thermostability

This fridge-free vaccine aims to address a well-documented challenge in global health: vaccine loss due to cold chain failures. According to the World Health Organization, around 50% of vaccines are wasted annually, often because they are compromised during transport or storage. Most conventional vaccines require strict temperature control, typically between 2°C and 8°C. Some even demand sub-zero storage.

SPVX02 has an 18-month shelf life at room temperature, which not only reduces the logistical burden but also minimizes dependence on refrigeration infrastructure. This has significant implications for vaccination campaigns in areas with unreliable electricity or limited refrigeration capacity.

Stablepharma’s innovation could help reduce these inefficiencies, making immunization programs more resilient, particularly during emergencies or in regions with poor access to cold-chain networks.

Government and EU-Backed Research

The current trial is funded through a combination of UK government support and European Union research initiatives. Funding support for the project has come from UK-based innovation bodies, including Innovate UK and NIHR, which back promising health technologies.

In February 2025, the company was awarded €2.5 million from the European Innovation Council Accelerator, following an earlier €50,000 grant from the Horizon Europe program in 2021.

These grants are part of broader efforts to advance vaccine innovation and improve preparedness for future health emergencies.

Professor Saul Faust, Director of the NIHR Southampton Clinical Research Facility, is leading the trial. He emphasized the significance of testing thermostable vaccines in human subjects, noting that it marks a turning point in vaccine delivery research.

Expanding the Platform Beyond SPVX02

Stablepharma views SPVX02 as just the beginning. The company has identified up to 60 existing vaccines that could be reformulated using the StablevaX™ platform. These include vaccines that are currently restricted by cold-chain requirements, such as those for polio, hepatitis, and measles.

Chief Development Officer Dr Karen O’Hanlon stated that SPVX02 demonstrates how thermostable vaccines can be produced at scale under Good Manufacturing Practice (GMP) conditions, paving the way for mass distribution without relying on refrigeration.

Should the trial outcomes remain positive, the company plans to launch SPVX02 commercially by 2027. The company believes that thermostable vaccines could play a key role in improving global vaccine coverage and reducing barriers to access.

Implications for Global Health

Fridge-free vaccines offer a practical solution to a persistent problem in immunization delivery. Their ability to remain effective outside a controlled environment could transform how vaccines are transported, stored, and administered—especially in remote, conflict-affected, or resource-poor regions.

If successful, the SPVX02 trial could validate a scalable model that significantly reduces vaccine spoilage and extends immunization reach.

As the trial progresses, researchers and health policymakers worldwide will be watching closely. The outcome may not only affect future vaccine logistics but also inform the next generation of biologic formulation technologies.

[Source]

The post Stablepharma Tests Fridge-Free Vaccine That Could Help Cut Global Wastage appeared first on Medical Journal Daily.

Early Quitters Reap the Biggest Rewards

According to the research, people who quit smoking by the age of 30 can gain up to a decade of extra life. The study shows that those who quit before 30 can see their health risks almost equal to those who have never smoked, reducing the likelihood of smoking-related diseases like lung cancer, heart disease, and respiratory conditions.

Middle-Aged Quitters Also See Major Health Gains

Even if someone doesn’t quit by 30, quitting between ages 40 to 50 still brings notable benefits. This age group can gain up to six to nine years of life by quitting. The study emphasizes that these gains are due to a lower risk of chronic diseases and improved overall health.

Benefits for Seniors: It’s Never Too Late

The research also found that older smokers, including those in their 60s or beyond, benefit from quitting. Quitting at an older age may not reverse all risks, but it does lower the chance of life-threatening conditions and can significantly improve quality of life. The study reinforces that it’s truly never too late to quit and experience positive health changes.

Health Systems and Support

The study calls for healthcare providers to focus on providing accessible and supportive resources for quitting smoking, as this can make a substantial difference in the quality and length of life for individuals across all age groups. Programs that offer counseling, nicotine replacement, and prescription aids can support people in every stage of the quitting process.

This research highlights that quitting smoking is beneficial at any stage, with earlier quitting offering the most substantial health advantages. The key takeaway: no matter your age, there are clear, life-extending benefits to giving up smoking.

The post Want to Live Longer? Science Shows How Quitting Smoking Helps at Any Age appeared first on Medical Journal Daily.